Alivus Life Sciences' Dahej Plant Resumes Operations After Fire Incident
Alivus Life Sciences Ltd, in compliance with the Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listin Regulations'), has informed about a fire incident that occurred on February 14, 2026, at their manufacturing facility in Dahej, Bharuch district, Gujarat. The incident was confined to one production block, affecting a portion of the intermediate manufacturing facilities, while the Active Pharmaceutical Ingredient (API) manufacturing facilities remained unaffected. The situation has been assessed and the company expects to resume API production from March 1, 2026, and intermediate production from mid-March 2026. This temporary cessation of manufacturing operations will result in delayed shipments. Alivus Life Sciences emphasizes safety and follows stringent safety standards and protocols across its operations.
Key Highlights
- Fire incident at Alivus Life Sciences' Dahej plant on February 14, 2026
- Incident confined to one production block, affecting intermediate manufacturing facilities
- API manufacturing facilities in the same block remained unaffected
- All other six production blocks at the Dahej site are unaffected and continue to remain fully operational
- Company expects to resume API production from March 1, 2026, and intermediate production from mid-March 2026